RxDoctor Payments Data

Casey Taber, MD

Orthopaedic Surgery · San Antonio, TXNPI 1972711463

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $82,011 of the $98,230 with a category attached, or 83.5%. Stryker accounts for 99.7% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2023 at $28,927 and has fallen 94.7% since, to $1,533 in 2025. Among orthopaedic surgery clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$98,230in general payments, 2019–2025

Across 139 payments — averaging $706.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$98K
  • Johnson & Johnson$85
  • Biocomposites Inc$40
  • Heron Therapeutics, Inc.$34
  • Pacira Therapeutics, Inc.$26
  • Astellas Pharma US Inc$22
  • plus $84 from 5 others
$1,000in research payments, 2019–2025

Across 1 payment — averaging $1000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medical Device Business Services, Inc.$1K

What the payments were for

  • Consulting fees$82,01183%
  • Travel & lodging$10,93511%
  • Food & beverage$5,2835%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$98,230 in reported general payments places this provider in the 90th percentile of 1,337 orthopaedic surgery providers in Texas.

See all orthopaedic surgery providers in Texas →

Medicare billing

Part B allowed, 2024
$491,087
Medicare patients
645
Services billed
5,386

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen234$2,748
Pregabalin108$1,294
Celecoxib107$1,186
Acetaminophen-CodeineAcetaminophen With Codeine51$473
Ibuprofen31$322
Methylprednisolone34$216
Gabapentin27$199
Tramadol Hcl39$147
Ondansetron OdtOndansetron13$119
Naproxen12$87
Cephalexin13$80
Amoxicillin83$60

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in San Antonio

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →